Home
About
Services
Partners
Client Portfolio
News
Contact
Exclusive: Toshiba considers liquidating UK nuke unit NuGen as sale talks drag
October 25, 2018
Strong results, bargain-hunting help Wall Street bounce back from rout
October 25, 2018
0
Merck, Bristol-Myers profits rise on cancer drug sales
Published by
Muller&Green
at
October 25, 2018
Categories
RSS
Tags
Merck & Co Inc and Bristol-Myers Squibb Co posted better-than-expected third quarter profit and raised their 2018 earnings forecasts on Thursday due to strong demand for their rival cancer immuno-oncology treatments.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more